Fiche société
Scholar Rock, Inc.
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| ApitegromabA randomized Phase 2 study to evaluate the efficacy and safety of apitegromab as a monotherapy in participant with FSHD | Myopathies | Phase 2 | À vérifier | United States | À vérifier |
| ApitegromabA randomized Phase 2 study to evaluate the efficacy and safety of apitegromab as a monotherapy in participant with FSHD | Myopathies | Phase 2 | À vérifier | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Apitegromab | Myopathies | Phase 2 | NCT07435129 | Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD | RECRUITING |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Apitegromab | Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway. | Expert review of neurotherapeutics | ||
| Apitegromab | Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial. | Nature medicine |